The 2018 ICCTF Cognition and Cancer Conference will be held in Sydney, Australia.
9-10th April 2018 Cognition and Cancer Conference
9th April: 6.30pm-10.30pm Conference Dinner @ Studio Sydney Tower (see below for further details)
11th April: 8.00am-11.00am optional Imaging and Pre-clinical workshops (running concurrently)
11th April: 1.00pm-4.00pm optional “meet the experts” networking buffet lunch cruise on Sydney harbor. www.captaincook.com.au
Rydge’s World Square, 389 Pitt Street NSW 2000, Sydney
THE ABSTRACT REVIEW PROCESS HAS NOW BEEN COMPLETED.
All submitting authors should have been notified of the outcome, please contact us at firstname.lastname@example.org if you haven’t received a notification e-mail. We have a very strong number of abstracts that have been selected for oral presentation at the conference and poster presentations which will be displayed over two sessions on Monday and Tuesday, 9th and 10th April.
We would encourage all presenters to register for the conference as soon as possible to confirm your participation and take advantage of the early bird rates, which finish on February 10th.
The ICCTF steering committee and local conference convenors would like to sincerely thank our panel of reviewers for their time, effort and expertise.
Twenty minutes in total: Presentations should be 15 minutes with 5 minutes for discussion.
Dimensions (maximum size): Height 147cm by width 97cm.
Please note the following important deadlines:
Abstract submission deadline: December 1st, 2017
Notification of acceptance of abstracts: end of January 2018
Early bird registration deadline: February 18th 2018
REGISTRATION FOR THE CONFERENCE IS OPEN.
To register for the conference click on the following link: https://sydney.OneStopSecure.com/onestopweb/ICCTF
Early bird registration has now closed.
Student Rate: early bird registration = 270 AUD. Full registration - after February 18th = 400 AUD
Regular Rate: early bird registration =500 AUD. Full registration - after February 18th = 650 AUD
If you are unable to attend the full conference there is an option to register to attend for one day only.
1-day registration rates (attending either Monday or Tuesday)
Student Rate: early bird registration = 175.00 AUD. Full registration - after February 18th = 250.00 AUD
Regular Rate: early bird registration = 300.00 AUD. Full registration - after February 18th = 375.00 AUD
Conference dinner: 110 AUD
Meet the Experts Networking Cruise: 100 AUD
Workshops: There will be two workshops - Imaging and Preclinical - running concurrently on Wednesday April 11th. Attendance is included in the conference registration fee. The workshops will run from 8.00-11.00am and are being held at the University of Sydney, which is easily accessible from the city by public transport. Further venue details will be provided closer to the date. Places are limited, please register to guarantee a spot.
You can contact the local organization by sending an email to: email@example.com
Dr Paul Maruff (University of Melbourne, Australia): The use of new technologies to assess cognition in oncology: opportunities and challenges
- Professor Paul Maruff is one of the founders of Cogstate. He is a neuropsychologist with expertise in the identification and measurement of subtle behavioural and cognitive dysfunction. Prof Maruff’s research integrates conventional and computerized neuropsychological testing with cognitive neuroscientific methods to guide decision making in drug development and in clinical medicine.
- He has worked extensively on method to identify subtle neurocognitive impairment, and to assess the efficacy of pharmacological treatment, in Alzheimer’s disease, mild cognitive impairment and the HIV dementia complex. He has extended this approach to identify cognitive dysfunction, and monitor treatment efficacy in psychiatric diseases such as schizophrenia, obsessive-compulsive disorder and depression in adults, and attention deficit disorder, developmental dyspraxia and substance abuse in children.
- Prof Maruff remains an active researcher. He is appointed Professor at the Florey Institute for Neuroscience and Mental Health. He is currently clinical co-chair of the Australian Imaging Biomakers and Lifestyle (AIBL) study. He has published over 250 research articles in international peer-reviewed scientific journals, and has co-authored 10 book chapters.
Dr Florence Joly (Centre Francois Baclesse Comprehensive Cancer Centre, France): Immunotherapy agents and cognition
- Professor Florence Joly is a medical oncologist in the Francois Baclesse Comprehensive Cancer Centre in Caen, Normandy, France. She did her training at the Universities of Grenoble and Caen, in France and undertook her fellowship in 2003 at the Princess Margaret Hospital in Toronto with Prof Ian Tannock.
- Prof Joly is the head of the Clinical Research Department of the François Baclesse Centre and Vice President of both the French Research Group on Supportive Care (AFSOS-Unicancer) and the GINECO group.
- She is involved in care and clinical research among patients with gynaecology and urinary cancers and is author and/or co-author of 186 indexed publications in the field of oncology.
- Prof Joly is a member of the research Unit INSERM U-1086, Anticipe (Lower Normandy University), and for 15 years she has been developing a large multidisciplinary research program on quality of life with two main topics – long term quality of life among survivors and impact of cancer treatments on cognition. She heads the Ligue labelled French cancer platform dedicated to Cancer and Cognition, supported by the North-West Canceropole (www.cancerandcognition.com). The platform includes multidisciplinary researchers and the group has developed studies from bench to bedside on chemotherapy in the elderly, targeted therapies, and a new generation of hormone-therapy.
Dr Adam Walker (Monash University, Australia): The influence of cancer on cognition in pre-clinical models
- Dr Adam Walker’s research program investigates the role of neuroinflammation in psychiatric illness and cognitive function. He completed his PhD at the University of Newcastle and undertook a successful postdoctoral fellowship at the prestigious MD Anderson Cancer Center, USA. Now located at Monash Institute of Pharmaceutical Sciences, Dr Walker is invested in novel drug design and repurposing safe available anti-inflammatories and other drugs to combat cancer-associated cognitive impairment.
- As a National Breast Cancer Foundation research fellow, Dr Walker is applying his expertise in neuroinflammation to identify novel mechanisms and treatments for chronic central nervous system (CNS)-related side-effects of cancer and cancer treatment. These mechanisms include neuroinflammation, the IDO-kynurenine pathway and blood-to-brain transport mechanisms. To accomplish this he uses syngenic, orthotopic mouse models of breast cancer metastasis to explore bidirectional communication between the brain and tumour. He has pioneered the repurposing of novel drugs and supplements (aspirin, ketamine and leucine) to treat inflammation and cancer-associated cognitive impairment and depression.
Dr Donald Mabbott (The Hospital for Sick Children, Canada): Cognitive and neuroimaging outcomes in cognitive/brain rehabilitation approaches
- Dr Donald Mabbott is a psychologist with the Paediatric Brain Tumour Program in the Division of Haematology/Oncology at The Hospital for Sick Children, a senior scientist in the Research Institute at The Hospital for Sick Children, and an associate professor in the Department of Psychology at the University of Toronto. He provides clinical neuropsychology services to children with brain tumours and their families and has a research program in developmental neuropsychology.
- Dr Mabbott’s research uses innovative brain imaging techniques (i.e. Diffusion Tensor Magnetic Resonance Imaging; Magnetoencephalography) and psychological tests to study the impact of brain injury on how the brain grows and develops in childhood. Specifically, he examines the impact of treatment for paediatric brain tumours on the structure and function of the brain.
- The overall goal of his research is to reduce the burden of brain tumours and their treatment to improve the quality of life for children. His work has been instrumental in documenting the thinking and learning difficulties children treated for brain tumours experience and the underlying damage to brain structure and function that cause these problems.
Professor Paul Maruff Professor Florence Joly Dr Adam Walker Dr Donald Mabbott
CONFERENCE ACCOMMODATION OPTIONS
We have organized a reduced rate for 30 rooms at the conference venue, Rydges World Square. This will be on a “first in / first served basis” and needs to be booked a minimum of one month prior to the conference to ensure you get this rate. Rate: AUD$209/night for a deluxe king/twin room.
To access the special accommodation rate, contact the Rydges World Square reservation team via phone (+61 2 8268 1888) or email (firstname.lastname@example.org) and quote BLOCK ID : 2988172 or BLOCK NAME: University of Sydney – Allotment. Credit card details are required to be provided for guarantee purposes at the time of booking.
Alternatively, Sydney offers a range of accommodation close to the city, including Darling Harbour and Circular Quay ranging from backpacker to 5-star hotels - as well as airbnb.
Monday 9th of April – Studio, Sydney Tower (6.30-10.30pm). Studio is Sydney’s highest event space and bar. The venue offers 220 degree views over Sydney that span across the Harbour, Sydney Harbour Bridge and the headlands.
http://s3.pixelcase.com/venues/bar/tour.html (interactive tour)
We would like to acknowledge the generous support of the Cancer Research Network (CRN), University of Sydney. The CRN, established in 2006, is a cross-Faculty initiative of the University. The CRN links cancer researchers in the University and its teaching hospitals and affiliated research institutes and institutions to build high quality cancer research capacity and achieve international cancer research excellence in areas of strength. For further information please visit the CRN's website: http://sydney.edu.au/cancer-research/